Disease · MONDO_0006031
Comparisons in its trials25
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 25
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Rimegepant vs Placebo: deaths from any cause | 0 of 99 | 0 of 105 | 204 | NCT05248997 | Trial comparisons |
| Rimegepant vs Placebo: serious adverse events | 0 of 99 | 0 of 105 | 204 | NCT05248997 | Trial comparisons |
| LYR-210 vs Sham Procedure Control: Participants With Rescue Treatments for CRS Through Week 24 | 12 of 124 | 7 of 66 | 190 | NCT05219968 | Trial comparisons |
| Glucocorticoid vs Clarithromycin: serious adverse events | 0 of 93 | 0 of 94 | 187 | NCT02182492 | Trial comparisons |
| LYR-210 vs Sham Procedure Control: Rescue Treatment Requirement Through Week 24 | 12 of 111 | 7 of 61 | 172 | NCT05295459 | Trial comparisons |
| LYR-210 vs Sham Procedure Control: deaths from any cause | 0 of 112 | 0 of 60 | 172 | NCT05295459 | Trial comparisons |
| LYR-210 vs Sham Procedure Control: serious adverse events | 2 of 112 | 0 of 60 | 172 | NCT05295459 | Trial comparisons |
| IV Acetaminophen vs Control: Number of Participants Who Received Intraoperative Supplemental Fentanyl | 9 of 31 | 4 of 29 | 60 | NCT01608308 | Trial comparisons |
| IV Acetaminophen vs Control: Number of Participants Who Experienced Postoperative Morbidity (Nausea) | 13 of 31 | 10 of 29 | 60 | NCT01608308 | Trial comparisons |
| IV Acetaminophen vs Control: serious adverse events | 0 of 31 | 0 of 29 | 60 | NCT01608308 | Trial comparisons |
| Xylitol vs Saline: deaths from any cause | 0 of 21 | 0 of 22 | 43 | NCT00924404 | Trial comparisons |
| Xylitol vs Saline: serious adverse events | 0 of 21 | 0 of 22 | 43 | NCT00924404 | Trial comparisons |
| Saline Plus Gentamycin (Once Daily, 40 mL to Each Nostril) vs Saline (Once Daily, 40 mL to Each Nostril): serious adverse events | 0 of 21 | 0 of 19 | 40 | NCT00465530 | Trial comparisons |
| Total Intravenous Anesthesia vs Inhaled Anesthesia: Quality of Recovery as Indicated by Number of Participants With Nausea | 1 of 12 | 1 of 11 | 23 | NCT01214057 | Trial comparisons |
| Total Intravenous Anesthesia vs Inhaled Anesthesia: Number of Participants for Whom Surgical Field Visualization Was Deemed Severely Compromised | 0 of 12 | 0 of 11 | 23 | NCT01214057 | Trial comparisons |
| Total Intravenous Anesthesia vs Inhaled Anesthesia: deaths from any cause | 0 of 12 | 0 of 11 | 23 | NCT01214057 | Trial comparisons |
| Total Intravenous Anesthesia vs Inhaled Anesthesia: serious adverse events | 0 of 12 | 0 of 11 | 23 | NCT01214057 | Trial comparisons |
| Buparid; Treatment A vs Budes; Treatment B: Safety Assessment | 6 of 10 | 6 of 9 | 19 | NCT01955980 | Trial comparisons |
| Buparid; Treatment A vs Budes; Treatment B: deaths from any cause | 0 of 10 | 0 of 9 | 19 | NCT01955980 | Trial comparisons |
| Buparid; Treatment A vs Budes; Treatment B: serious adverse events | 1 of 10 | 0 of 9 | 19 | NCT01955980 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0006031/comparisons